The New Map of Crohn’s Disease: Beyond Inflammation

Crohn’s disease treatment is undergoing a radical transformation.
This week, Advancements in Gastroenterology explores the emerging science reshaping how we understand and manage inflammatory bowel disease — from global trends in pediatric IBD and the promise of GLP-1 receptor agonists to the precision power of biologics like risankizumab and novel insights into the tuft cell–IL-25 axis.
Join us as we uncover how the gut-brain connection, microbiome modulation, and personalized medicine are rewriting the future of Crohn’s disease care.